GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tourmaline Bio Inc (NAS:TRML) » Definitions » PB Ratio

Tourmaline Bio (Tourmaline Bio) PB Ratio : 1.44 (As of May. 12, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Tourmaline Bio PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-12), Tourmaline Bio's share price is $14.50. Tourmaline Bio's Book Value per Share for the quarter that ended in Dec. 2023 was $10.08. Hence, Tourmaline Bio's PB Ratio of today is 1.44.

The historical rank and industry rank for Tourmaline Bio's PB Ratio or its related term are showing as below:

TRML' s PB Ratio Range Over the Past 10 Years
Min: 0   Med: 0   Max: 6.85
Current: 1.44

During the past 3 years, Tourmaline Bio's highest PB Ratio was 6.85. The lowest was 0.00. And the median was 0.00.

TRML's PB Ratio is ranked better than
68.12% of 1311 companies
in the Biotechnology industry
Industry Median: 2.5 vs TRML: 1.44

Back to Basics: PB Ratio


Tourmaline Bio PB Ratio Historical Data

The historical data trend for Tourmaline Bio's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tourmaline Bio PB Ratio Chart

Tourmaline Bio Annual Data
Trend Dec21 Dec22 Dec23
PB Ratio
- - 2.60

Tourmaline Bio Quarterly Data
Dec21 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23
PB Ratio Get a 7-Day Free Trial - - - - 2.60

Competitive Comparison of Tourmaline Bio's PB Ratio

For the Biotechnology subindustry, Tourmaline Bio's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tourmaline Bio's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tourmaline Bio's PB Ratio distribution charts can be found below:

* The bar in red indicates where Tourmaline Bio's PB Ratio falls into.



Tourmaline Bio PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Tourmaline Bio's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=14.50/10.082
=1.44

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Tourmaline Bio  (NAS:TRML) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Tourmaline Bio PB Ratio Related Terms

Thank you for viewing the detailed overview of Tourmaline Bio's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Tourmaline Bio (Tourmaline Bio) Business Description

Traded in Other Exchanges
N/A
Address
27 West 24th Street, Suite 702, New York, NY, USA, 10010
Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases.